Felip E, Cho BC, Nguyen D, Curtin JC, et al. Reply to the Letter to the Editor regarding 'PFS, OS or toxicity: what is the most important factor in the treatment of EGFR-mutated lung cancer?' by T. Nishimura and H. Fujimoto. Ann Oncol 2024 Nov 8:S0923-7534(24)04060-2. doi: 10.1016/j.annonc.2024.
PMID: 39521680